Search
Pharmacological Interventions
The use of medication to manage withdrawal symptoms, reduce cravings, or treat co-occurring mental health disorders e.g., methadone, buprenorphine, naltrexone.
The Synaptic Interactions of Alcohol and the Endogenous Cannabinoid System
ABSTRACT
PURPOSE: A growing body of evidence has implicated the endocannabinoid (eCB) system in the acute, chronic, and withdrawal effects of alcohol/ethanol on synaptic function. These eCB-mediated synaptic effects may contribute to the...
Abuse Potential of Cathinones in Humans: A Systematic Review
Abstract
Introduction and objective: Assessing the abuse potential of new substances with central nervous system activity is essential for preventing possible risks of misuse and addiction. The same methodology is recommended for the...
UTC-1 Training by Nishan Rehab Pakistan, Jan 6,7,8, 2022 at Multan, Pakistan
“Training of Addiction Professionals for Pakistan Addiction Treatment Practitioners”
January 6, 7 & 8th, 2022
Multan, Islamic Republic of Pakistan
- Description:
- Training Name: Training of Addiction Professionals for Pakistan
- L...
EMCDDA initial report on the new psychoactive substance 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC)
1-(3-Chlorophenyl)-2-(methylamino) propan-1-one (3-chloromethcathinone, 3-CMC) is a synthetic cathinone stimulant. It is a ring-substituted cathinone, which is structurally related to methcathinone and 4-chloromethcathinone (4-CMC).
The...
Three days of online training on Assisted Pharmacological Treatment of Opioid Dependence in Côte d'Ivoire
As part of efforts to improve the quality of and access to evidence-based treatment and care services for people with drug use disorders and in support of the recent official launch of the methadone pilot programme in Côte d'Ivoire, UNODC...
What are the evidence-based treatment options for methamphetamine use disorder?
This webinar provided attendees with information about:
1. Overview of the clinical challenges associated with methamphetamine use disorder
2. Psychosocial approaches for methamphetamine use disorder
3. Pharmacological treatments being...
Methadone maintenance treatment
Document of the Ministry of Health and Social Protection of Colombia that presents baseline of the maintenance programs with methadone in the country and the profile of the population served and the general characteristics of the treatment...
Work Environment Factors and Prevention of Opioid-Related Deaths
Opioid use disorder (OUD) and opioid overdose deaths (OODs) are prevalent among US workers, but work-related factors have not received adequate attention as either risk factors or opportunities for OOD prevention. Higher prevalence of OOD...
Biochemical mechanisms associating alcohol use disorders with cancers
Abstract
The World Health Organization identifies alcohol as a cause of several neoplasias of the oropharynx cavity, esophagus, gastrointestinal tract, larynx, liver, or female breast. We review ethanol’s nonoxidative and oxidative...
Designer Drugs
Designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests...
Call for Abstracts: International Society of Addiction Medicine 2021 Conference
Abstracts on all aspects of addiction are welcome. In 2021, we especially encourage abstracts that focus on exploring global solutions to international problems in the field of addiction medicine, including:
- Drug, alcohol and non...
Cannabis Use in People With Obsessive-Compulsive Symptomatology: Results From a Mexican Epidemiological Sample
Recent studies suggest that the endocannabinoid system could play an important role in the physiopathology of obsessive-compulsive disorder (OCD). There are reports of effective treatment with derivatives of tetrahydrocannabinol (THC). The...
Addressing Unprecedented Challenges in Management of SUD’s and GBV in the midst of COVID-19
ISSUP Kenya would like to present their Webinar on Addressing Unprecedented Challenges in Management of SUD's and GBV in the midst of COVID-19. The Webinar will explore emerging trends in Substance Use Disorder and Gender-based violence in view of COVID-19 and the correlations between SUD’s and GBV, with special emphasis of the impact of COVID-19.
The rapidly changing composition of the global street drug supply and Its effects on high-risk groups for COVID-19
The majority of street drugs, in some cases more than ninety-five percent, now have multiple toxic adulterants. This research review brings to the attention of public health officials, addiction medicine specialists, treatment officials, therapists, and the general public the alarming increase of dangerous toxic adulterants being added to street drugs and their potentially lethal synergistic effects.
Comorbid Psychiatric Disorders in Patients suffering from Substance Use Disorder
ISSUP Pakistan would like to present their Webinar on the topic of Comorbid Psychiatric Disorders in Patients suffering from Substance Use Disorder.
Variation in Cannabinoid Metabolites Present in the Urine of Adults Using Medical Cannabis Products in Massachusetts
The findings of this cohort study are consistent with those of a study of cannabis products purchased in California and Washington, in which more than one-half of products were incorrectly labeled. These findings indicate that adults using...
The Short-Term Impact of 3 Smoked Cannabis Preparations versus Placebo on PTSD Symptoms: A Randomized Cross-Over Clinical Trial
Abstract
Importance
There is a pressing need for development of novel pharmacology for the treatment of Posttraumatic Stress Disorder (PTSD). Given increasing use of medical cannabis among US military veterans to self-treat PTSD...
Webinar | Preventing and Treating Substance Use Disorders: A Focus on Females Across the Life Course
As part of International Women's Day 2021, ISSUP Lebanon are pleased to have presented their Webinar with Dr. Hendrée Jones on the topic of treatment and prevention of substance use disorders among females across the life span.
EMCDDA Technical Report on New Psychoactive Substance
The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (commonly known as 4F-MDMB-BICA), a synthetic receptor cannabinoid...
National trainer teams from Central Asia level up in the Universal Treatment Curriculum for Substance Use Disorders with support from UNODC
Online regional training for trainers (ToT) on Course 10 “Managing Medication-Assisted Treatment Programs” (30 November – 3 December 2020) of the Advanced Level of the Universal Treatment Curriculum for Substance Use Disorders (UTC training...
